About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Oncology
›
top-articles
Department of Oncology
68
(top 1%)
papers
3.3K
(top 1%)
citations
27
(top 1%)
h
-index
57
(top 1%)
g
-index
71
all documents
3.4K
doc citations
1.0K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene
FOXO1
in Endometrial Cancer
Cancer Research
2010
308
2
Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand
18
F-AH111585 in Breast Cancer Patients
Journal of Nuclear Medicine
2008
279
3
FOXO transcription factors: key regulators of cell fate
Biochemical Society Transactions
2006
198
4
Transcriptional Cross Talk between the Forkhead Transcription Factor Forkhead Box O1A and the Progesterone Receptor Coordinates Cell Cycle Regulation and Differentiation in Human Endometrial Stromal Cells
Molecular Endocrinology
2007
189
5
Differential Expression of FOXO1 and FOXO3a Confers Resistance to Oxidative Cell Death upon Endometrial Decidualization
Molecular Endocrinology
2006
162
6
Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
Molecular and Cellular Biology
2007
158
7
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [
18
F]-labeled isatin sulfonamide
Proceedings of the National Academy of Sciences of the United States of America
2009
157
8
Patient‐derived xenografts for individualized care in advanced sarcoma
Cancer
2014
154
9
The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor α in Breast Cancer Cells
Journal of Biological Chemistry
2006
152
10
The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
Molecular and Cellular Biology
2008
150
11
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Breast Cancer Research
2009
134
12
Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells
Oncogene
2008
130
13
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity
Journal of Molecular Endocrinology
2008
108
14
CD3 limits the efficacy of TCR gene therapy in vivo
Blood
2011
101
15
FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression
Journal of Biological Chemistry
2008
87
16
Adjuvant mitozantrone chemotherapy in advanced prostate cancer
BJU International
2001
85
17
Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy
International Journal of Gynecological Cancer
2000
84
18
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
British Journal of Cancer
2011
74
19
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells
Breast Cancer Research and Treatment
2011
70
20
The involvement of sphingosine kinase 1 in LPS‐induced Toll‐like receptor 4‐mediated accumulation of HIF‐1α protein, activation of ASK1 and production of the pro‐inflammatory cytokine IL‐6
Immunology and Cell Biology
2011
59
21
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
British Journal of Cancer
2016
56
22
Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response
British Journal of Cancer
2009
50
23
Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A
Oncogene
2009
50
24
The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27Kip1
Virology
2010
38
25
PI3K pathway-directed therapeutic strategies in cancer
Current Opinion in Investigational Drugs
2010
36
26
Dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study
Alimentary Pharmacology and Therapeutics
2014
30
27
Epstein-Barr Virus Represses the FoxO1 Transcription Factor through Latent Membrane Protein 1 and Latent Membrane Protein 2A
Journal of Virology
2006
27
28
Kinetic filtering of [
18
F]Fluorothymidine in positron emission tomography studies
Physics in Medicine and Biology
2010
27
29
HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions
Oncogene
2010
24
30
Pleurodesis for malignant pleural effusions
The Cochrane Library
2013
23
31
Long Term Outcome in Adolescents with Hodgkin's Lymphoma: Poor Results using Regimens Designed for Adults
Leukemia and Lymphoma
2004
21
32
Mechanisms of androgen receptor repression in prostate cancer
Biochemical Society Transactions
2006
17
33
Intensification of Growth Factor Receptor Signalling by Phorbol Treatment of Ligand-primed Cells Implies a Dimer-stabilizing Effect of Protein Kinase C-dependent Juxtamembrane Domain Phosphorylation
Cellular Signalling
1999
14
34
Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands
BMC Bioinformatics
2008
14
35
Capsaicin-sensitive primary sensory neurons in the mouse express N-Acyl phosphatidylethanolamine phospholipase D
Neuroscience
2009
14
36
Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules
International Journal of Radiation Oncology Biology Physics
1999
13
37
Targeting cell cycle kinases and kinesins in anticancer drug development
Expert Opinion on Drug Discovery
2007
13
38
Gene therapy for prostate cancer
Seminars in Cancer Biology
1997
12
39
Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage
International Journal of Biochemistry and Cell Biology
2012
12
40
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial
Expert Review of Anticancer Therapy
2008
11
41
90Y Radioembolization: Embolization of the Gastroduodenal Artery is not Always Appropriate
CardioVascular and Interventional Radiology
2010
10
42
Cerebral Sinus Thrombosis and Leptomeningeal Carcinomatosis in a Patient With Ovarian Cancer
Journal of Clinical Oncology
2012
10
43
Ultrasound-guided trans-rectal high-intensity focused ultrasound (HIFU) for advanced cervical cancer ablation is feasible: a case report
Journal of Therapeutic Ultrasound
2015
10
44
PSA and prostate cancer diagnosis
European Journal of Cancer
1996
9
45
Abc-06: a Randomised Phase Iii, Multi-Centre, Open-Label Study of Active Symptom Control (Asc) Alone or Asc with Oxaliplatin / 5-Fu Chemotherapy for Patients with Locally Advanced / Metastatic Biliary Tract Cancers (Abc) Previously Treated with Cisplatin / Gemcitabine Chemotherapy.
Annals of Oncology
2014
9
46
Is prostate cancer worth diagnosing?
Lancet, The
1995
7
47
No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer
Aids
2010
7
48
Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas
Future Oncology
2010
7
49
The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma
Hepatic Oncology
2016
7
50
Chemotherapy for prostate cancer
Urologic Oncology: Seminars and Original Investigations
2000
6
site/software ©
exaly
; All materials licenced under
CC by-SA
.